Did You Know?

Editor’s Picks

Latest News

Clinical Trial of the Oral Drug NV-387 to Treat Ebola Has Started Enrollment and Dosing of Patients Last Week (on or about September 23rd), Says NanoViricides

SHELTON, CT / ACCESS Newswire / September 28, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...

Cosmos Health’s Contract Manufacturing Division Surpasses $20 Million in Implied Revenue and $18 Million in Implied Gross Profit Across Its Record 32.7 Million-Unit Production Pipeline

Contract manufacturing pipeline surpasses $20 million in implied revenue at wholly owned subsidiary Cana Laboratories, representing over $18 million in...

Global IP Thought Leaders, Scholars, and Policymakers to Gather in Paris for “Competing for the Cure” Conference on Biopharmaceutical Ecosystems

PARIS, FR / ACCESS Newswire / September 28, 2026 / On October 29-30, 2026, the Berkeley Policy Institute's Eira Initiative...

AI in Clinical Trials Market to Reach USD 7.32 Billion by 2034 as AI Reshapes Patient Recruitment, Data Analysis and Drug Development, says Maximize Market Research

error: Content is protected !!